2015
DOI: 10.1007/s40005-015-0190-3
|View full text |Cite
|
Sign up to set email alerts
|

Development of phenytoin intranasal microemulsion for treatment of epilepsy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
14
0
2

Year Published

2015
2015
2023
2023

Publication Types

Select...
6
2

Relationship

2
6

Authors

Journals

citations
Cited by 16 publications
(16 citation statements)
references
References 12 publications
0
14
0
2
Order By: Relevance
“…In addition to that, intranasal drug delivery enables reduction in the dose, quick therapeutic level attainment of the drug into the blood, speedier onset of pharmacological activity, and fewer side effects ( Arora et al, 2002 , Ugwoke et al, 2001 ). It is reported that lipophilic drugs are by and large, well absorbed from the nasal cavity with pharmacokinetic profiles, which are frequently indistinguishable to those acquired after an intravenous infusion with a bioavailability approaching 100% ( Aacharya et al, 2015 ). Strategy of delivering the drug by intranasal route could be effective in the delivery of therapeutic proteins such as brain delivered neurotropic factor (BDNF) to the olfactory bulb as a treatment for Alzheimer’s disease ( Thorne et al, 1995 ).…”
Section: Introductionmentioning
confidence: 99%
“…In addition to that, intranasal drug delivery enables reduction in the dose, quick therapeutic level attainment of the drug into the blood, speedier onset of pharmacological activity, and fewer side effects ( Arora et al, 2002 , Ugwoke et al, 2001 ). It is reported that lipophilic drugs are by and large, well absorbed from the nasal cavity with pharmacokinetic profiles, which are frequently indistinguishable to those acquired after an intravenous infusion with a bioavailability approaching 100% ( Aacharya et al, 2015 ). Strategy of delivering the drug by intranasal route could be effective in the delivery of therapeutic proteins such as brain delivered neurotropic factor (BDNF) to the olfactory bulb as a treatment for Alzheimer’s disease ( Thorne et al, 1995 ).…”
Section: Introductionmentioning
confidence: 99%
“…Measured volume of distilled water was added dropwise to the above mixture and vortexed to obtain transparent microemulsion. 20,21 The composition of microemulsions was showed in Table 1.…”
Section: Preparation Methods Microemulsionsmentioning
confidence: 99%
“…Ex vivo drug diffusion study was carried out using freshly obtained sheep nasal mucosal epithelium from slaughter house (Arumugam et al, 2008;Jung et al, 2009;Acharya et al, 2015;Lohan et al, 2015). Mucosal membrane (0.2 mm thick, 10 mm diameter and 78.5 mm 2 area) was fixed in between receptor and donor compartment of the Franz diffusion cell.…”
Section: Ex Vivo % Drug Diffusion (%Dd)mentioning
confidence: 99%
“…Although various strategies have been applied to attain brain delivery of QTF, still requires further improvement (Kararli et al, 1992;Lohan et al, 2015). Several studies reported that lipophilic drugs are generally well absorbed from the nasal route with pharmacokinetic profiles (Ding et al, 2007), which are frequently indistinguishable to those acquired after an intravenous infusion with a bioavailability approaching 100% (Acharya et al, 2015).…”
Section: Introductionmentioning
confidence: 99%